To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The organization will share ...

Recent reports suggest that there are now no redesigned Apple Vision headsets in active development, with the company's focus pivoting decisively to smart glasses. Soon after the launch of the Vision ...

The Africa Development Forum (ADF) book series is a partnership between the World Bank’s Africa Chief Economist Office and Agence Française de Développement, coordinated by World Bank Publications. To ...

Vietnam’s economic rise has been extraordinary. The country has made a triple transition from central planning to a market economy, from import substitution to export-led integration and from extreme ...

Europe’s battery storage market continues to evolve at a breakneck pace, with new hot spots emerging across the continent. Equity and debt providers are showing greater confidence in the asset class ...

From September 8 to 12, leaders from across the Pacific Islands region gathered in Honiara, Solomon Islands, for the 54th Pacific Islands Forum Leaders Meeting (PIFLM). This annual gathering convenes ...

Distance-running plans are chock-full of workouts that improve metrics like VO2 max and lactate threshold to help you run faster for longer. But coach Scott Johnston looks beyond these traditional ...

A special election to fill the City Council seat is set for September 9. Voting signs outside of a Tampa polling place on Election Day in 2023. Election day for the District 5 race is September 9, ...

The people of Harrisburg came together Monday night -- just to talk. It may be a night to remember. It wasn’t all of the city’s nearly 50,000 residents by a long shot, but the people who met at ...

New York, 23 July 2025 – The 2025 High-Level Political Forum on Sustainable Development (HLPF) concluded this week with Member States calling for urgent, coordinated action to accelerate progress on ...

Sarepta Therapeutics’ report of a second fatality this year in a patient dosed with its Duchenne muscular dystrophy gene therapy raised the prospect it might have to pull the product from the market.